GPIIb/IIIa Receptor Antagonism Using Small Molecules Provides no Additive Long-Term Protection after Percutaneous Coronary Intervention as Compared to Clopidogrel Plus Aspirin
与氯吡格雷联合阿司匹林相比,使用小分子拮抗GPIIb/IIIa受体并不能在经皮冠状动脉介入治疗后提供额外的长期保护作用。
期刊:Open Cardiovascular Medicine Journal
影响因子:0.4
doi:10.2174/1874192401004010151
Schiariti, Michele; Saladini, Angela; Papalia, Francesco; Grillo, Placido; Nesta, Cristina; Cuturello, Domenico; Missiroli, Bindo; Puddu, Paolo Emilio